Lyumjev (insulin lispro-aabc) for the Treatment of Type 1 and Type 2 Diabetes

Image 3-Lyumjev (insulin lispro-aabc)
The FDA approval of Lyumjev was based on the findings from PRONTO clinical trial programme. Credit: Eli Lilly and Company.